Cumberland Pharmaceuticals Inc. Advertising Expense
Cumberland Pharmaceuticals Inc. (CPIX) reported Advertising Expense of $2.73 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-03-09
- Cumberland Pharmaceuticals Inc. advertising expense for fiscal 2025 was $2.73M, a 8.55% decline from fiscal 2024.
- Cumberland Pharmaceuticals Inc. advertising expense for fiscal 2024 was $2.99M, a 2.89% increase from fiscal 2023.
- Cumberland Pharmaceuticals Inc. advertising expense for fiscal 2023 was $2.90M, a 0.80% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. advertising expense for fiscal 2022 was $2.93M, a 51.83% increase from fiscal 2021.
| Period end | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.73M 10-K · filed 2026-03-09 | |
| 2024-12-31 | $2.99M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $2.90M 10-K · filed 2025-03-07 | |
| 2022-12-31 | $2.93M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $1.93M 10-K · filed 2023-03-13 | |
| 2020-12-31 | $2.38M 10-K · filed 2022-03-11 | |
| 2019-12-31 | $2.59M 10-K · filed 2022-03-11 | $2.69M 10-K · filed 2020-03-20 |
| 2018-12-31 | $2.01M 10-K · filed 2021-03-12 | $2.22M 10-K · filed 2019-03-12 |
| 2017-12-31 | $2.38M 8-K · filed 2020-12-10 | $2.59M 10-K · filed 2018-03-09 |
| 2016-12-31 | $2.63M 10-K · filed 2019-03-12 | $2.60M 10-K · filed 2017-03-13 |
| 2015-12-31 | $2.58M 10-K · filed 2018-03-09 | $2.60M 10-K · filed 2016-03-14 |
| 2014-12-31 | $2.50M 10-K · filed 2017-03-13 | |
| 2013-12-31 | $2.10M 10-K · filed 2016-03-14 | |
| 2012-12-31 | $3.00M 10-K · filed 2015-03-09 | $1.80M 10-K · filed 2013-03-12 |
| 2011-12-31 | $900.00K 10-K · filed 2014-03-11 | |
| 2010-12-31 | $800.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |